Items where Author is "Rahalkar, Hasumati"
Number of items: 5.
Evaluation of the Regulatory Requirements for Development and Approval of Biosimilar Medicines in the BRICS-TM Countries: Improving Patients' Access. (2021)
Hasumati Rahalkar
![]()
Current Regulatory Requirements for Biosimilars in Six Member Countries of BRICS-TM: Challenges and Opportunities. (2021)
Hasumati Rahalkar,
Alan Sheppard,
Gustavo Mendes Lima Santos,
Chitralekha Dasgupta,
Sonia Mayra Perez-Tapia,
Carlos A. Lopez-Morales
and
Sam Salek
![]()
Comparison of BRICS-TM Countries' Biosimilar Regulatory Frameworks With Australia, Canada and Switzerland: Benchmarking Best Practices. (2021)
Hasumati Rahalkar,
Alan Sheppard
and
Sam Salek
![]()
Challenges Faced by the Biopharmaceutical Industry in the Development and Marketing Authorization of Biosimilar Medicines in BRICS-TM Countries: An Exploratory Study. (2021)
Hasumati Rahalkar,
Alan Sheppard,
Carlos Augusto Lopez-Morales,
Luciano Lobo
and
Sam Salek
![]()
Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory Guidelines. (2018)
Hasumati Rahalkar,
Hacer Coskun Cetintas
and
Mir-Saeed Shayegan Salek
![]()